BIGG

Resultados: 35

ACR Appropriateness Criteria® Female breast cancer screening: 2023 update

J. Am. Coll. Radiol; 21 (6S), 2024
Early detection of breast cancer from regular screening substantially reduces breast cancer mortality and morbidity. Multiple different imaging modalities may be used to screen for breast cancer. Screening recommendations differ based on an individual’s risk of developing breast cancer. Numerous factor...

Chinese national clinical practice guidelines on the prevention, diagnosis, and treatment of early gastric cancer

Chin. med. j; 137 (8), 2024
Gastric cancer is one of the most common malignant tumors in the digestive system in China. Few comprehensive practice guidelines for early gastric cancer in China are currently available. Therefore, we created the Chinese national clinical practice guideline for the prevention, diagnosis, and treatment ...

AGA clinical practice update on risk stratification for colorectal cancer screening and post-polypectomy surveillance: expert review

Gastroenterology; 165 (5), 2023
Since the early 2000s, there has been a rapid decline in colorectal cancer (CRC) mortality, due in large part to screening and removal of precancerous polyps. Despite these improvements, CRC remains the second leading cause of cancer deaths in the United States, with approximately 53,000 deaths projected...

Screening for colorectal cancer in asymptomatic average-risk adults: a guidance statement from the American College of Physicians (version 2)

Ann. intern. med; 176 (8), 2023
The purpose of this updated guidance statement is to guide clinicians on screening for colorectal cancer (CRC) in asymptomatic average-risk adults. The intended audience is all clinicians. The population is asymptomatic adults at average risk for CRC. This updated guidance statement was developed using r...

Maligní melanom: diagnostika a léčba
Malignant melanoma: diagnosis and treatment

Maligní melanom kůže představuje agresivní zhoubný nádor kůže neuroektodermového původu, který vychází z melanocytů bazální vrstvy epidermis. Tento nádor zaujímá přibližně 4 % ze všech zhoubných kožních tumorů, avšak je zodpovědný až za 65–75 % případů úmrtí asociov...

PET-CT v diagnostice a kontrole léčby onkologických onemocnění
PET-CT in the diagnosis and control of the treatment of oncological diseases

Pozitronová emisní tomografie (PET) v kombinaci s výpočetní tomografií, popř. s magnetickou rezonancí je zobrazovací vyšetřovací metoda nukleární medicíny. Využívá cíleného funkčního zobrazení specifických vlastností buněk pomocí radiofarmak. Největší uplatnění má PET v s...

Tamización primaria con prueba ADN-VPH en mujeres menores de 30 años: evaluación de tecnología sanitaria

Antecedentes A partir del 2014 en Colombia se incorporó la Tamización primaria con prueba de Virus del Papiloma Humano (VPH) desde los 30 hasta los 65 años, cuando la prueba es positiva se hace triage con citología para remisión a colposcopia. Actualmente se discute la conveniencia de iniciar la tam...

WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (‎HPV)‎

This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. This document includes guidance on an important additional option for cervical screening, the use of mRNA (messenger RNA) HPV testing. This gives countries a...

Suspected cancer: recognition and referral: Last updated 15 December 2021

This guideline covers identifying children, young people and adults with symptoms that could be caused by cancer. It outlines appropriate investigations in primary care, and selection of people to refer for a specialist opinion. It aims to help people understand what to expect if they have symptoms that ...

Screening for Lung Cancer: CHEST guideline and expert panel report

Chest; (21), 2021
Low-dose chest CT screening for lung cancer has become a standard of care in the United States, in large part because of the results of the National Lung Screening Trial (NLST). Additional evidence supporting the net benefit of low-dose chest CT screening for lung cancer, and increased experience in mini...